ZVRA logo

Zevra Therapeutics, Inc. (ZVRA)

Profile

Full Name

Zevra Therapeutics, Inc.

Ticker Symbol

NASDAQ: ZVRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 16, 2015

Indexes

Not included

Website

http://zevra.com

Employees

59

Key Details

Price

$9.74(+3.51%)

Market cap

$532.58M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$23.61M(-14.02% YoY)

Annual EPS

-$2.28(-75.38% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.74
    ZVRA price is $9.74

    30-Day Relative Volume

    1.92
    ZVRA 30-day relative volume is 1.92

    Price Performance

    Price Most recent change

    +3.51%
    ZVRA price was up +3.51% on Jul 3, 2025

    Price YTD change

    +16.79%
    ZVRA price is up +16.79% since January 1st

    Price 1-year change

    +126.25%
    ZVRA price is up +126.25% year-on-year

    Price 3-year change

    +116.44%
    ZVRA price is up +116.44% over the past 3 years

    Price Range

    Price All-time high

    $418.40
    ZVRA price is currently -97.67% below its historical high of $418.40

    Price 3-year low

    $3.89
    ZVRA price is currently +150.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $532.58M
    ZVRA market capitalization is $532.58 million

    Market cap 3-year change

    +243.15%
    ZVRA market capitalization is up +243.15% over the past 3 years

    Market cap All-time high

    $532.58M
    ZVRA market capitalization is currently at an all-time high

    Market cap sector rank

    67.92%
    ZVRA market capitalization is higher than 67.92% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +30.22%
    ZVRA shares outstanding is up +30.22% year-on-year

    Shares Outstanding 3-Year Change

    +58.54%
    ZVRA shares outstanding is up +58.54% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    ZVRA beta is 0.66

    200-day SMA

    $8.19
    ZVRA price is currently +18.92% above its 200-day simple moving average

    50-day SMA

    $8.51
    ZVRA price is currently +14.45% above its 50-day simple moving average

    RSI

    65.76
    ZVRA 14-day relative strength index is 65.76

    Volume

    1.92
    ZVRA 30-day relative volume is 1.92

    ATR

    $0.45
    ZVRA average true range is $0.45

    10-day Historical Volatility

    39.80%
    ZVRA 10-day historical volatility is 39.80%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $23.61M
    ZVRA annual revenue is $23.61 million

    Revenue Analysts estimate

    $93.17M
    ZVRA annual revenue is currently -74.66% lower than the consensus analysts' forecast

    Revenue 1-year change

    -14.02%
    ZVRA annual revenue is down -14.02% year-on-year

    Revenue Sector rank

    35.49%
    ZVRA annual revenue is higher than 35.49% of companies in Healthcare sector

    EPS

    EPS

    -$2.28
    ZVRA annual earnings per share is -$2.28

    EPS Analysts estimate

    $1.09
    ZVRA annual earnings per share is currently -308.91% lower than the consensus analysts' forecast

    EPS 1-year change

    -75.38%
    ZVRA annual earnings per share is down -75.38% year-on-year

    EPS Sector rank

    36.8%
    ZVRA annual earnings per share is higher than 36.8% of companies in Healthcare sector

    Profit

    Gross profit

    $16.20M
    ZVRA annual gross profit is $16.20 million

    Gross margin

    68.59%
    ZVRA annual gross profit margin is 68.59%

    Operating profit

    -$87.00M
    ZVRA annual operating income is -$87.00 million

    Operating margin

    -368.47%
    ZVRA annual operating profit margin is -368.47%

    Net income

    -$105.51M
    ZVRA annual net profit is -$105.51 million

    Net margin

    -446.85%
    ZVRA annual net profit margin is -446.85%

    Expenses

    Total expenses

    $110.61M
    ZVRA annual total expenses is $110.61 million

    Operating expenses

    $103.20M
    ZVRA annual total operating expenses is $103.20 million

    Cost of goods sold

    $7.42M
    ZVRA annual cost of goods sold is $7.42 million

    Selling, general & administrative expenses

    $54.87M
    ZVRA annual SGA is $54.87 million

    Depreciation and amortization

    $6.39M
    ZVRA annual depreciation & amortization is $6.39 million

    Interest expense

    $7.35M
    ZVRA annual interest expense is $7.35 million

    Income tax

    $15.37M
    ZVRA annual income tax is $15.37 million

    EBIT & EBITDA

    EBIT

    -$82.79M
    ZVRA annual earnings before interest & taxes is -$82.79 million

    EBITDA

    -$76.55M
    ZVRA annual EBITDA is -$76.55 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $178.13M
    ZVRA annual total assets is $178.13 million

    Non current assets

    $92.10M
    ZVRA annual long term assets is $92.10 million

    Current assets

    $86.03M
    ZVRA annual total current assets is $86.03 million

    Cash and cash equivalents

    $33.78M
    ZVRA annual cash & cash equivalents is $33.78 million

    Accounts receivable

    $10.18M
    ZVRA annual accounts receivable is $10.18 million

    Inventory

    $1.97M
    ZVRA annual inventory is $1.97 million

    Liabilities

    Total liabilities

    $138.46M
    ZVRA annual total liabilities is $138.46 million

    Long term liabilities

    $104.40M
    ZVRA annual total long term liabilities is $104.40 million

    Current liabilities

    $34.06M
    ZVRA annual total current liabilities is $34.06 million

    Accounts payable

    $13.07M
    ZVRA annual accounts payable is $13.07 million

    Debt

    Total debt

    $60.30M
    ZVRA annual total debt is $60.30 million

    Total debt 1-year change

    +37.77%
    ZVRA annual total debt is up +37.77% year-on-year

    Long term debt

    $59.88M
    ZVRA annual long term debt is $59.88 million

    Short term debt

    $420.00K
    ZVRA annual short term debt is $420.00 thousand

    Equity & Capital

    Shareholders equity

    $39.67M
    ZVRA annual stockholders equity is $39.67 million

    Book value

    $39.67M
    ZVRA annual book value is $39.67 million

    Retained earnings

    -$505.29M
    ZVRA annual retained earnings is -$505.29 million

    Working capital

    $51.96M
    ZVRA annual working capital is $51.96 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$69.67M
    ZVRA annual cash flow from operations is -$69.67 million

    Cash from operations 1-year change

    -107.74%
    ZVRA annual cash flow from operations is down -107.74% year-on-year

    Cash from investing

    -$22.16M
    ZVRA annual cash flow from investing activities is -$22.16 million

    Cash from investing 1-year change

    -27.44%
    ZVRA annual cash flow from investing activities is down -27.44% year-on-year

    Cash from financing

    $82.11M
    ZVRA annual cash flow from financing activities is $82.11 million

    Cash from financing 1-year change

    +188.46%
    ZVRA annual cash flow from financing activities is up +188.46% year-on-year

    CAPEX

    CAPEX

    -
    ZVRA annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ZVRA annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$69.67M
    ZVRA annual free cash flow is -$69.67 million

    Free cash flow 1-year change

    -105.92%
    ZVRA annual free cash flow is down -105.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    68.59%
    ZVRA annual gross profit margin is 68.59%

    Operating margin

    -368.47%
    ZVRA annual operating profit margin is -368.47%

    Net margin

    -446.85%
    ZVRA annual net profit margin is -446.85%

    ROA & ROE

    ROA

    -60.21%
    ZVRA annual return on assets is -60.21%

    ROE

    -207.84%
    ZVRA annual return on equity is -207.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ZVRA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ZVRA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    12.98
    ZVRA price to book ratio is 12.98

    PB ratio Sector rank

    92.61%
    ZVRA price to book ratio is higher than 92.61% of companies in Healthcare sector

    PS Ratio

    PS ratio

    13.12
    ZVRA price to sales ratio is 13.12

    PS ratio Sector rank

    81.3%
    ZVRA price to sales ratio is higher than 81.3% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $557.08M
    ZVRA enterprise value is $557.08 million

    Enterprise value Sector rank

    68.24%
    ZVRA enterprise value is higher than 68.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.24
    ZVRA EV/EBITDA is -9.24

    EV/EBITDA Sector rank

    14.67%
    ZVRA EV/EBITDA is higher than 14.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.53
    ZVRA annual current ratio is 2.53

    Quick ratio

    2.47
    ZVRA annual quick ratio is 2.47

    Leverage

    Debt to equity

    1.50
    ZVRA annual debt to equity ratio is 1.50

    Interest coverage ratio

    -11.26
    ZVRA annual interest coverage ratio is -11.26

    Risk & Stability

    Piotroski F-Score

    3
    ZVRA piotroski f-score is 3

    Altman Z-Score

    -2.71
    ZVRA altman z-score is -2.71

    Analyst ratings

    Recent major analysts updates

    Jul 2, 25 HC Wainwright & Co.
    Buy
    May 14, 25 Cantor Fitzgerald
    Overweight
    Mar 13, 25 HC Wainwright & Co.
    Buy
    Mar 13, 25 Guggenheim
    Buy
    Mar 13, 25 Canaccord Genuity
    Buy
    Mar 12, 25 Citizens Capital Markets
    Market Outperform
    Mar 12, 25 Cantor Fitzgerald
    Overweight
    Nov 20, 24 HC Wainwright & Co.
    Buy
    Nov 14, 24 Canaccord Genuity
    Buy
    Oct 11, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with ZVRA included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    • What is the ticker symbol for Zevra Therapeutics, Inc.?
    • Does Zevra Therapeutics, Inc. pay dividends?
    • What sector is Zevra Therapeutics, Inc. in?
    • What industry is Zevra Therapeutics, Inc. in?
    • What country is Zevra Therapeutics, Inc. based in?
    • When did Zevra Therapeutics, Inc. go public?
    • Is Zevra Therapeutics, Inc. in the S&P 500?
    • Is Zevra Therapeutics, Inc. in the NASDAQ 100?
    • Is Zevra Therapeutics, Inc. in the Dow Jones?
    • When was Zevra Therapeutics, Inc.'s last earnings report?
    • When does Zevra Therapeutics, Inc. report earnings?

    What is the ticker symbol for Zevra Therapeutics, Inc.?

    The ticker symbol for Zevra Therapeutics, Inc. is NASDAQ:ZVRA

    Does Zevra Therapeutics, Inc. pay dividends?

    No, Zevra Therapeutics, Inc. does not pay dividends

    What sector is Zevra Therapeutics, Inc. in?

    Zevra Therapeutics, Inc. is in the Healthcare sector

    What industry is Zevra Therapeutics, Inc. in?

    Zevra Therapeutics, Inc. is in the Biotechnology industry

    What country is Zevra Therapeutics, Inc. based in?

    Zevra Therapeutics, Inc. is headquartered in United States

    When did Zevra Therapeutics, Inc. go public?

    Zevra Therapeutics, Inc.'s initial public offering (IPO) was on April 16, 2015

    Is Zevra Therapeutics, Inc. in the S&P 500?

    No, Zevra Therapeutics, Inc. is not included in the S&P 500 index

    Is Zevra Therapeutics, Inc. in the NASDAQ 100?

    No, Zevra Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Zevra Therapeutics, Inc. in the Dow Jones?

    No, Zevra Therapeutics, Inc. is not included in the Dow Jones index

    When was Zevra Therapeutics, Inc.'s last earnings report?

    Zevra Therapeutics, Inc.'s most recent earnings report was on May 13, 2025

    When does Zevra Therapeutics, Inc. report earnings?

    The next expected earnings date for Zevra Therapeutics, Inc. is August 13, 2025
    On this page